• Gotham and Mercachem generate epitranscriptomic target library pharmaceutical-technology
    July 18, 2019
    New York-based RNA-focused drug discovery company Gotham Therapeutics and German contract research organization (CRO) Mercachem have announced they have created a high-quality compound library focused on epitranscriptomic drug discovery.
PharmaSources Customer Service